Literature DB >> 889679

Hodgkin's disease in children.

I E Smith, M J Peckham, T J McElwain, J C Gazet, D E Austin.   

Abstract

Fifty-nine children with Hodgkin's disease were seen over a 34-year period. Compared with Hodgkin's disease in adults, there was an increased male incidence, especially in the younger children. This was associated with an increased male incidence of lymphocyte-predominant histology. Forty-six patients underwent lymphography as part of their staging, and 13 had staging laparotomies. The 5-year survival for the entire group was 85%, with a median survival of 10 years. Response to radiotherapy in children with Stages I-IIIA disease was: 12 children treated with involved-field radiotherapy after inadequate clinical staging had a 3-year remission rate of 13%, and a median length of remission of 18 months; 24 children treated with extended-field radiotherapy after adequate clinical staging, including lymphography, had a 3-year remission rate of 72%, and a median duration of remission not yet reached; 3 children treated with elective local radiotherapy for Stage IA disease after intensive clinical staging remain in complete remission for periods of up to 34 months. Eight out of 10 children with Stages IIIB-IV disease, treated with combination chemotherapy, achieved complete remission with a 3-year remission rate of 70%; 7 children treated with combination chemotherapy following relapse after radiotherapy all achieved complete remission with a 3-year complete remission rate of 66%. Thirteen children underwent laparotomy and splenectomy as a staging procedure. Five were found to have intra-abdominal disease, including 4 with splenic involvement. These results show that there is no place for involved-field radiotherapy after inadequate clinical staging, in the management of childhood Hodgkin's disease. Extended-field radiotherapy after adequate staging, and combination chemotherapy, produce results which are as good as those for adults, but the benefits of these treatments and of staging laparotomy must be balanced against the possible complications when they are used in children. These problems are discussed and a scheme of management is proposed.

Entities:  

Mesh:

Year:  1977        PMID: 889679      PMCID: PMC2025432          DOI: 10.1038/bjc.1977.162

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Chemotherapy oif childhood Hodgkin's disease in Uganda.

Authors:  J L Ziegler; L Fass; A Z Bluming; I T Magrath; A C Templeton
Journal:  Lancet       Date:  1972-09-30       Impact factor: 79.321

2.  Results of regional radiotherapy in localized Hodgkin's disease in children.

Authors:  L M Fuller; M P Sullivan; J J Butler
Journal:  Cancer       Date:  1973-09       Impact factor: 6.860

3.  Combination chemotherapy in advanced and recurrent Hodgkin's disease.

Authors:  T J McElwain; P F Wrigley; A Hunter; D Crowther; J S Malpas; M J Peckham; D W Smithers; G H Fairley
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

4.  Intensive chemotherapy for Hodgkin's disease: long-term complications.

Authors:  V T DeVita; J C Arseneau; R J Sherins; G P Canellos; R C Young
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

5.  Hodgkin's disease in childhood.

Authors:  R C Young; V T DeVita; R E Johnson
Journal:  Blood       Date:  1973-08       Impact factor: 22.113

6.  Laparotomy for the staging of Hodgkin's disease in children.

Authors:  D M Hays; R E Hittle; H Isaacs; M R Karon
Journal:  J Pediatr Surg       Date:  1972 Oct-Nov       Impact factor: 2.545

7.  A critique of the value of laparotomy and splenectomy in the evaluation of patients with Hodgkin's disease.

Authors:  S A Rosenberg
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

8.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

9.  Hodgkin's disease in the first decade of life.

Authors:  S B Strum; H Rappaport
Journal:  Pediatrics       Date:  1970-11       Impact factor: 7.124

10.  Letter: Chemotherapy of Hodgkin's disease.

Authors:  C L Olweny; E K Mbidde; J Nkwocha; I Magrath; J L Ziegler
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

View more
  2 in total

1.  Chemotherapy and irradiation in childhood Hodgkin's disease.

Authors:  B Robinson; J Kingston; R Nogueira Costa; J S Malpas; A Barrett; T J McElwain
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

2.  Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.

Authors:  P J Dady; T J McElwain; D E Austin; A Barrett; M J Peckham
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.